Pancreatic Cancer Research

ResearcherNorth Sichuan Medical UniversityNo recent work listed

Yu Pu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-7461-3788; OpenAlex author ID A5012053582. Sources: OpenAlex.

Their work

Papers
5 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: 1 paper · 2023: 1 paper

Papers 5

  1. Superparamagnetic iron oxide nanoparticles target BxPC-3 cells and silence MUC4 for the treatment of pancreatic cancer. Co-author DOI 10.1016/j.bbagen.2023.130383↗
  2. Effect of F11R Gene Knockdown on Malignant Biological Behaviors of Pancreatic Cancer Cells. Co-author DOI 10.1155/2022/3379027↗
  3. IL10-modified Human Mesenchymal Stem Cells inhibit Pancreatic Cancer growth through Angiogenesis Inhibition. First author DOI 10.7150/jca.38062↗
  4. The effect of superparamagnetic iron oxide with iRGD peptide on the labeling of pancreatic cancer cells in vitro: a preliminary study. Co-author DOI 10.1155/2014/852352↗
  5. MR imaging of human pancreatic cancer xenograft labeled with superparamagnetic iron oxide in nude mice. First author DOI 10.1002/cmmi.465↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Haidi Zhang · 2 shared papers, 2020–2022 · strength 0.27
  2. Bo Mu · 2 shared papers, 2020–2022 · strength 0.27
  3. Xianhua Hu · 2 shared papers, 2020–2022 · strength 0.27
  4. Chunyan Zhao · 2 shared papers, 2020–2022 · strength 0.27
  5. Shilin Li · 1 shared paper, 2023 · strength 0.19
  6. Xiao Ming Zhang · 2 shared papers, 2012–2014 · strength 0.08
  7. Hou Dong Zuo · 1 shared paper, 2014 · strength 0.04
  8. Chao Ying Wu · 1 shared paper, 2012 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.